To help researchers understand diseases that are difficult to diagnose like cancer and Alzheimer’s, an innovative Canadian preclinical imaging device company known as Cubresa has immersed itself in the intellectually-rich Massachusetts life sciences sector by opening the doors of its U.S. office in the Cambridge Innovation Center.
Cambridge Mayor David Maher (center) with Co-Founder of Canadian Technology Accelerator and Trade Commissioner of Life Sciences Business Development at the Consulate General of Canada Christine Sarkisian (left), Cubresa Founder James Schellenberg (second from left), MLSC Vice President for Communications & Marketing Angus McQuilken (second from right) and Manager of Business Development at Cubresa Helena Mistry (right).
